rs199837807
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3PP5
The NM_001298.3(CNGA3):c.869G>A(p.Arg290His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000321 in 1,614,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001298.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGA3 | ENST00000272602.7 | c.869G>A | p.Arg290His | missense_variant | Exon 8 of 8 | 1 | NM_001298.3 | ENSP00000272602.2 | ||
CNGA3 | ENST00000436404.6 | c.815G>A | p.Arg272His | missense_variant | Exon 7 of 7 | 1 | ENSP00000410070.2 | |||
CNGA3 | ENST00000409937.1 | n.1022G>A | non_coding_transcript_exon_variant | Exon 8 of 8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251390Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135882
GnomAD4 exome AF: 0.000337 AC: 492AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.000323 AC XY: 235AN XY: 727234
GnomAD4 genome AF: 0.000171 AC: 26AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74458
ClinVar
Submissions by phenotype
Achromatopsia Pathogenic:1
- -
Retinal dystrophy Pathogenic:1
- -
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 290 of the CNGA3 protein (p.Arg290His). This variant is present in population databases (rs199837807, gnomAD 0.03%). This missense change has been observed in individual(s) with achromatopsia (PMID: 30418171). ClinVar contains an entry for this variant (Variation ID: 503561). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CNGA3 protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on CNGA3 function (PMID: 30418171). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
CNGA3-related disorder Uncertain:1
The CNGA3 c.869G>A variant is predicted to result in the amino acid substitution p.Arg290His. This variant was reported together with homozygous pathogenic variant in CNGB3 gene in an individual with retinopathy (Burkard et al. 2018. PubMed ID: 30418171). Functional study of this variant expressed heterologously showed that this variant results in normal functional protein with lower affinity for CNGB3 which in summary suggests there is no convincing evidence of pathogenicity of this variant at this time (Burkard et al. 2018. PubMed ID: 30418171). This variant was also observed in large exome study in a healthy individual and was assessed as likely pathogenic carrier variant (Table S1, Capalbo et al 2019. PubMed ID: 31589614). This variant is reported in 0.029% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-99012502-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at